Close Menu

This Week in Nature

In Nature this week, research led by Novartis' Feng Cong identified a new molecule in the Wnt signaling pathway that could potentially be a target in Wnt-dependent cancers. Using a chemical genetic screen, the scientists found that XAV939, a small molecule that selectively inhibits beta-catenin-mediated transcription, effectively stabilizes axin.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Nature News reports that researchers in Japan hope to soon test the use of reprogrammed stem cells to treat damaged corneas.

A new approach may help limit the number of fish that are mislabeled at markets or restaurants, according to New Scientist.

At Slate, the R Street Institute's Nila Bala discusses the privacy rights of suspects that genetic genealogy approaches in law enforcement bring up.

In PNAS this week: numerous mobile genetic elements contribute to Vibrio cholerae drug resistance, troponin I mutations in sudden infant deaths, and more.